ABSTRACT
Query fever is a zoonotic disease caused by Coxiella burnetii. There is no universal method for the prevention of this disease. Recombinant vaccine is a potent strategy that can be utilized for this purpose. The current study was conducted to develop a multi-epitope vaccine against Coxiella burnetii. Hence, OmpA, Tuf2, GroEL, Mip and sucB antigens were used for the prediction of epitopes. Then, a multi-epitope vaccine was developed based on a molecular adjuvant and fragments that contained the best MHCI, B cell, MHCII and IFN-γ epitopes. The features of the developed vaccine including physicochemical parameters, antigenicity and protein structures were assessed. Also, interaction between the developed vaccine and TLR4/MD2 receptor along with molecular dynamics of the ligand-receptor complex were investigated. Finally, the codon adaptation and cloning were conducted for the developed vaccine. According to the results, molecular weight, instability index, antigenicity and random coil percentage of the developed vaccine were 54.4â¯kDa, 32.84, 1.1936 and 34.92%, respectively. Besides, residues distribution in core region of the refined model was 85%. The results demonstrated that the developed vaccine could dock to its receptor with the lowest energy of -976.7 as well as RMSD value of the complex was between 0.15 and 0.22â¯nm. Also, the results showed that CIA index of the codon adapted sequence was 0.95. Finally, cloning results revealed that nucleotide sequence of the developed vaccine could be successfully cloned into pET-21a (+). Based on these results, it seems that the developed vaccine can be a suitable candidate to prevent Coxiella burnetii.
Subject(s)
Bacterial Vaccines/immunology , Bacterial Zoonoses/prevention & control , Coxiella burnetii/immunology , Epitopes, B-Lymphocyte/immunology , Molecular Docking Simulation/methods , Molecular Dynamics Simulation , Q Fever/prevention & control , Amino Acid Sequence , Animals , Antigens, Bacterial/immunology , Bacterial Outer Membrane Proteins/chemistry , Bacterial Outer Membrane Proteins/immunology , Bacterial Vaccines/chemistry , Chaperonin 60/chemistry , Chaperonin 60/immunology , Epitopes, B-Lymphocyte/chemistry , Histocompatibility Antigens Class I/chemistry , Histocompatibility Antigens Class I/immunology , Histocompatibility Antigens Class II/chemistry , Histocompatibility Antigens Class II/immunology , Humans , Ketoglutarate Dehydrogenase Complex/chemistry , Ketoglutarate Dehydrogenase Complex/immunology , Lymphocyte Antigen 96/chemistry , Protein Structure, Secondary , Protein Structure, Tertiary , Q Fever/immunology , Q Fever/microbiology , Toll-Like Receptor 4/chemistryABSTRACT
Autoantibodies to intracellular targets in mitochondria and nuclei are serological hallmarks of primary biliary cirrhosis (PBC). One of the most recently identified cellular targets of PBC autoantibodies is a novel cytoplasmic structure referred to as GW bodies [GWB, G (glycine) W (tryptophan)-containing bodies (GWB)]. GWB are indentified as discrete cytoplasmic domains that are involved in mRNA processing via the RNA interference (RNAi) pathway. Key components of GWB include the proteins GW182, Ago2, RNA-associated protein 55 (RAP55) and Ge-1/Hedls. The primary objective was to study the frequency and clinical association of antibodies directed to GWB components, in 109 PBC patients. Autoantibodies to mitochondrial antigen-pyruvate dehydrogenase complex (M2), branched-chain 2-oxo-acid dehydrogenase complex and 2-oxo glutarate dehydrogenase complex (3E-BPO), gp210, sp100, promyelocytic leukaemia cell antigen (PML) and liver kidney microsomal-1 antigen (LKM-1) were detected by a line immunoassay and antibodies to GWB (GW182, RAP55, Ge-1, GW2, GW3) and glutamate receptor interacting protein (GRIP)-associated protein-1 (GRASP-1), by an addressable laser bead immunoassay (ALBIA). The most common GWB autoantigen targets were: RAP55-28%, GW182-12%, GW2-2% and antibodies to GRASP-1-17%. By comparison, the frequency of reactivity to established PBC autoantigens was: gp210, 27%; sp100, 27% and PML, 17%. None of the autoantibodies were associated with differences in Mayo risk score or liver decompensation. This study is the first study to show that antibodies to RAP55, GW182 and GRASP-1 are the most common GWB targets in PBC.
Subject(s)
Autoantibodies/immunology , Autoantigens/immunology , Cytoplasmic Structures/immunology , Liver Cirrhosis, Biliary/immunology , Adult , Aged , Antigens, Nuclear/immunology , Female , Humans , Ketoglutarate Dehydrogenase Complex/immunology , Male , Middle Aged , Nuclear Pore Complex Proteins/immunology , Nuclear Proteins/immunology , Promyelocytic Leukemia Protein , Proteins/immunology , Pyruvate Dehydrogenase Complex/immunology , RNA-Binding Proteins/immunology , Retrospective Studies , Ribonucleoproteins/immunology , Transcription Factors/immunology , Tumor Suppressor Proteins/immunology , Young AdultABSTRACT
T cells are known to cross-react with diverse peptide MHC Ags through their alphabeta TCR. To explore the basis of such cross-reactivity, we examined the 2C TCR that recognizes two structurally distinct ligands, SIY-K(b) and alloantigen QL9-L(d). In this study we characterized the cross-reactivity of several high-affinity 2C TCR variants that contained mutations only in the CDR3alpha loop. Two of the TCR lost their ability to cross-react with the reciprocal ligand (SIY-K(b)), whereas another TCR (m67) maintained reactivity with both ligands. Crystal structures of four of the TCRs in complex with QL9-L(d) showed that CDR1, CDR2, and CDR3beta conformations and docking orientations were remarkably similar. Although the CDR3alpha loop of TCR m67 conferred a 2000-fold higher affinity for SIY-K(b), the TCR maintained the same docking angle on QL9-L(d) as the 2C TCR. Thus, CDR3alpha dictated the affinity and level of cross-reactivity, yet it did so without affecting the conserved docking orientation.
Subject(s)
Complementarity Determining Regions/chemistry , H-2 Antigens/metabolism , Oligopeptides/metabolism , Receptors, Antigen, T-Cell, alpha-beta/chemistry , Amino Acid Sequence , Animals , Complementarity Determining Regions/genetics , Complementarity Determining Regions/metabolism , Conserved Sequence , Cross Reactions/genetics , Cross Reactions/immunology , H-2 Antigens/chemistry , H-2 Antigens/genetics , Histocompatibility Antigen H-2D , Ketoglutarate Dehydrogenase Complex/genetics , Ketoglutarate Dehydrogenase Complex/immunology , Ketoglutarate Dehydrogenase Complex/metabolism , Mice , Molecular Sequence Data , Oligopeptides/chemistry , Oligopeptides/genetics , Oligopeptides/immunology , Protein Binding/genetics , Protein Binding/immunology , Protein Transport/genetics , Protein Transport/immunology , Receptors, Antigen, T-Cell, alpha-beta/genetics , Receptors, Antigen, T-Cell, alpha-beta/metabolismABSTRACT
alphabeta T cell receptors (TCRs) can crossreact with both self- and foreign- major histocompatibility complex (MHC) proteins in an enigmatic phenomenon termed alloreactivity. Here we present the 2.35 A structure of the 2C TCR complexed with its foreign ligand H-2L(d)-QL9. Surprisingly, we find that this TCR utilizes a different strategy to engage the foreign pMHC in comparison to the manner in which it recognizes a self ligand H-2K(b)-dEV8. 2C engages both shared and polymorphic residues on L(d) and K(b), as well as the unrelated QL9 and dEV8 peptide antigens, in unique pair-wise contacts, resulting in greater structural complementarity with the L(d)-QL9 complex. In the structure of an engineered, high-affinity 2C TCR variant bound to H-2L(d)-QL9, the "wild-type" TCR-MHC binding orientation persists despite modified TCR-CDR3alpha interactions with peptide. Thus, a single TCR recognizes two globally similar, but distinct ligands by divergent mechanisms, indicating that receptor-ligand crossreactivity can occur in the absence of molecular mimicry.
Subject(s)
Autoantigens/immunology , H-2 Antigens/immunology , Isoantigens/immunology , Receptors, Antigen, T-Cell, alpha-beta/immunology , Amino Acid Sequence , Autoantigens/chemistry , Autoantigens/metabolism , Complementarity Determining Regions/metabolism , Crystallography, X-Ray , H-2 Antigens/chemistry , H-2 Antigens/metabolism , Histocompatibility Antigen H-2D , Isoantigens/chemistry , Isoantigens/metabolism , Ketoglutarate Dehydrogenase Complex/chemistry , Ketoglutarate Dehydrogenase Complex/immunology , Ligands , Models, Molecular , Molecular Sequence Data , Peptides/chemistry , Peptides/immunology , Peptides/metabolism , Protein Binding , Receptors, Antigen, T-Cell, alpha-beta/chemistry , Receptors, Antigen, T-Cell, alpha-beta/metabolismABSTRACT
Primary biliary cirrhosis is a chronic cholestatic liver disease of unknown cause that predominantly affects middle-aged women. Distal tubular acidosis is the main renal complication of primary biliary cirrhosis. Tubulointerstitial nephritis and Fanconi syndrome have been reported more rarely. We report on 2 patients with primary biliary cirrhosis who presented with tubulointerstitial nephritis and Fanconi syndrome and review similar cases published previously. Serum from 1 patient exerted an inhibitory effect on pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase, 2 mitochondrial enzymes that are the main targets of antimitochondrial antibodies in primary biliary cirrhosis. Antimitochondrial antibodies may have a role in the genesis of tubulointerstitial nephritis and Fanconi syndrome, 2 typical renal features of mitochondrial cytopathies. Tubulointerstitial nephritis and Fanconi syndrome have to be added to the spectrum of renal diseases associated with primary biliary cirrhosis.
Subject(s)
Autoantibodies/immunology , Autoimmune Diseases/complications , Fanconi Syndrome/etiology , Liver Cirrhosis, Biliary/complications , Nephritis, Interstitial/etiology , Acidosis, Renal Tubular/etiology , Adrenal Cortex Hormones/therapeutic use , Aged , Antibodies, Antinuclear/immunology , Autoantigens/immunology , Autoimmune Diseases/immunology , Autoimmune Diseases/pathology , Biopsy , Bone Diseases, Metabolic/etiology , Calcitriol/therapeutic use , Fanconi Syndrome/immunology , Fanconi Syndrome/pathology , Female , Humans , Ketoglutarate Dehydrogenase Complex/immunology , Kidney/pathology , Kidney Failure, Chronic/etiology , Liver/pathology , Liver Cirrhosis, Biliary/immunology , Liver Cirrhosis, Biliary/pathology , Middle Aged , Mitochondria/immunology , Mitochondria, Liver/enzymology , Nephritis, Interstitial/immunology , Nephritis, Interstitial/pathology , Phosphates/blood , Pyruvate Dehydrogenase Complex/immunology , Ursodeoxycholic Acid/therapeutic useABSTRACT
We analyzed the protein components contained in the mitochondrial nucleoid (mt-nucleoid) fraction of the yeast Saccharomyces cerevisiae. Immunoblotting with anti-Abf2p antibody demonstrated the association of Abf2p, a major mitochondrial DNA-binding protein, with the mt-nucleoids. In contrast, porin and cytochrome c oxidase subunit III (CoxIIIp) were not detected by immunoblotting in the mt-nucleoid fraction. The YMN-1 monoclonal antibody recognized a 48 kDa protein of the mt-nucleoid fraction. The N-terminal amino acid sequence of the protein and immunological evidence showed that the YMN-1 monoclonal antibody recognizes dihydrolipoyl transsuccinylase (KE2), which is one of the constituents of the alpha-ketoglutarate dehydrogenase complex (KGDC). alpha-Ketoglutarate dehydrogenase (KE1) and dihydrolipoyl dehydrogenase (E3), which are other subunits of KGDC, were also detected in the mt-nucleoid fraction. An enzyme assay of the mt-nucleoid fraction showed that cytochrome c oxidase and fumarase activity were barely detected in the fraction, but the specific activity of KGDC in the mt-nucleoid fraction was relatively high and was approximately 60% of the specific activity in the mitochondrial fraction. Three components of KGDC were detected in the DNA-binding protein fractions after DNA-cellulose column chromatography of mt-nucleoid proteins. These results suggested that a part of KGDC in the mitochondrial matrix is associated with mt-nucleoids in vivo.
Subject(s)
Antigens, Fungal/analysis , Antigens, Fungal/immunology , Ketoglutarate Dehydrogenase Complex/analysis , Ketoglutarate Dehydrogenase Complex/immunology , Mitochondria/enzymology , Saccharomyces cerevisiae/cytology , Saccharomyces cerevisiae/enzymology , Acyltransferases/analysis , Acyltransferases/chemistry , Acyltransferases/immunology , Amino Acid Sequence , Antibodies, Monoclonal/immunology , Antigens, Fungal/chemistry , Dihydrolipoamide Dehydrogenase/analysis , Dihydrolipoamide Dehydrogenase/chemistry , Dihydrolipoamide Dehydrogenase/immunology , Electrophoresis, Gel, Two-Dimensional , Immunoblotting , Ketoglutarate Dehydrogenase Complex/chemistry , Mitochondria/immunology , Molecular Sequence Data , Molecular Weight , Protein Subunits , Saccharomyces cerevisiae/immunology , Saccharomyces cerevisiae Proteins/analysis , Saccharomyces cerevisiae Proteins/chemistry , Saccharomyces cerevisiae Proteins/immunologyABSTRACT
T cells are activated by binding of the T cell receptor (TCR) to a peptide-major histocompatibility complex (MHC) complex (pMHC) expressed on the surface of antigen presenting cells. Various models have predicted that activation is limited to a narrow window of affinities (or dissociation rates) for the TCR-pMHC interaction and that above or below this window, T cells will fail to undergo activation. However, to date there have not been TCRs with sufficiently high affinities in order to test this hypothesis. In this report we examined the activity of a CD8-negative T cell line transfected with a high affinity mutant TCR (K(D) = 10 nM) derived from cytotoxic T lymphocyte clone 2C by in vitro engineering. The results show that despite a 300-fold higher affinity and a 45-fold longer off-rate compared with the wild-type TCR, T cells that expressed the mutant TCRs were activated by peptide. In fact, activation could be detected at significantly lower peptide concentrations than with T cells that expressed the wild-type TCR. Furthermore, binding and functional analyses of a panel of peptide variants suggested that pMHC stability could account for apparent discrepancies between TCR affinity and T cell activity observed in several prior studies.
Subject(s)
Antigen Presentation/immunology , CD8 Antigens/immunology , Ketoglutarate Dehydrogenase Complex/immunology , Lymphocyte Activation/immunology , Oligopeptides/immunology , Receptors, Antigen, T-Cell, alpha-beta/immunology , T-Lymphocytes/immunology , Interleukin-2/biosynthesis , Major Histocompatibility Complex/immunology , Mutagenesis , Peptides/immunology , Receptors, Antigen, T-Cell, alpha-beta/genetics , TransfectionABSTRACT
CTL clone 2C recognizes the allogeneic class I MHC molecule L(d) in association with peptides derived from alpha-ketoglutarate dehydrogenase (oxoglutarate dehydrogenase (OGDH)), a ubiquitous intracellular protein. One of these peptides, QLSPFPFDL (QL9), elicits more vigorous cytolytic responses than two previously identified naturally processed peptides with overlapping sequences, LSPFPFDL (p2Ca) and VAITRIEQLSPFPFDL (p2Cb), from OGDH. In this study, we show that QL9 forms a more stable complex with cell surface L(d) than does p2Ca or p2Cb and is processed from the longer, naturally occurring peptide p2Cb by 20S proteosomes in vitro. The N-terminal cyclized pyroglutaminyl QL9 (pyroQL9), a form of QL9 to which it is converted at the low pH used for peptide isolation from tissue extracts, is even more active than QL9 in cytotoxicity assays with 2C CTL. Overall, the results indicate that along with the abundant natural peptides p2Ca and p2Cb, the QL9 and other OGDH peptides of various lengths, sharing a conserved C-terminal sequence, are also processed and presented with L(d) as allogeneic ligands for T cells expressing 2C TCR. All these peptides, each available in a low amount, could act in concert at the cell surface, resulting in a high density of cognate ligands that accounts for the exceptionally potent cytolytic response by 2C CTL.
Subject(s)
Cytotoxicity, Immunologic , H-2 Antigens/metabolism , Oligopeptides/immunology , T-Lymphocytes, Cytotoxic/immunology , Alanine/genetics , Amino Acid Sequence , Animals , Binding, Competitive/genetics , Binding, Competitive/immunology , Cell Line , Cell Line, Transformed , Clone Cells , Conserved Sequence , Cysteine Endopeptidases/metabolism , Cytotoxicity Tests, Immunologic , Cytotoxicity, Immunologic/genetics , Endoplasmic Reticulum/genetics , Endoplasmic Reticulum/immunology , Endoplasmic Reticulum/metabolism , Histocompatibility Antigen H-2D , Humans , Hydrolysis , Ketoglutarate Dehydrogenase Complex/genetics , Ketoglutarate Dehydrogenase Complex/immunology , Ketoglutarate Dehydrogenase Complex/metabolism , Mice , Molecular Sequence Data , Molecular Weight , Multienzyme Complexes/metabolism , Mutagenesis, Site-Directed , Oligopeptides/chemical synthesis , Oligopeptides/genetics , Oligopeptides/metabolism , Peptide Fragments/genetics , Peptide Fragments/immunology , Peptide Fragments/metabolism , Proteasome Endopeptidase Complex , Protein Binding/genetics , Protein Binding/immunology , Pyrrolidonecarboxylic Acid/metabolism , Receptors, Antigen, T-Cell/immunology , T-Lymphocytes, Cytotoxic/metabolism , TransfectionABSTRACT
THE RESEARCH OBJECTIVE: of this study was to test whether variation in mitochondrial composition is associated with "selective vulnerability" in Alzheimer brain. The term "selective vulnerability" refers to the loss of relatively vulnerable brain cells and the sparing of relatively resistant brain cells in disorders in which a genetic defect or environmental agent acts on both types of cells. The mechanisms underlying selective vulnerability are largely unknown, but mitochondria may be involved; the composition of mitochondria varies among different types of neurons, and mitochondria have an important role in cell death. Alzheimer's Disease (AD) is one of a number of neurodegenerative disorders in which both selective vulnerability and abnormalities of mitochondria occur. METHODS: We examined by immunohistochemistry the cellular distribution of a mitochondrial constituent (the alpha-ketoglutarate dehydrogenase complex, KGDHC) known to be deficient in AD, in relation to the known selective vulnerability of neurons in areas 21 and 22 of the temporal lobe in this neurodegenerative disorder. RESULTS: In normal human brain, cortical layers III and V contain neurons intensely immunoreactive for KGDHC, compared to other cells in these areas. The KGDHC-enriched cells are lost in AD (p < 0.001). In layer III, the loss of KGDHC-enriched cells is proportional to total loss of neurons, as determined by immunoreactivity to neuron specific enolase (NSE). In layer V, a higher proportion of the KGDHC-enriched neurons are lost than of other (NSE positive) neurons (p < 0.001). SIGNIFICANCE: Variations in mitochondrial composition may be one of the factors determining which cells die first when different types of cells are exposed to the same stress.
Subject(s)
Alzheimer Disease/enzymology , Alzheimer Disease/pathology , Ketoglutarate Dehydrogenase Complex/analysis , Mitochondria/enzymology , Temporal Lobe/enzymology , Temporal Lobe/pathology , Aged , Autopsy , Biopsy , Cell Count , Cell Death , Female , Glial Fibrillary Acidic Protein/analysis , Humans , Immunohistochemistry , Ketoglutarate Dehydrogenase Complex/immunology , Male , Middle Aged , Neurons/enzymology , Phosphopyruvate Hydratase/analysisABSTRACT
Primary biliary cirrhosis (PBC) is characterized by an immune mediated, irreversible destruction of the small intrahepatic bile ducts leading to progressive liver cirrhosis and frequently to liver failure. The course of the disease is variable and an early diagnosis is desirable to identify individuals with rapidly progressing disease, to initiate adequate therapeutic measures and to evaluate the necessity of liver transplantation. Serological tests represent the single most important diagnostic feature of PBC because liver histology, biochemistry, or clinical syndrome alone are not reliable in this respect. The molecular definition of the autoantigen targets of antimitochondrial antibodies (AMA) has resulted in the development of reproducible and effective serological testing strategies. AMA directed against the ketoacid dehydrogenase complex are highly disease-specific but not directed against liver-specific target structures. Despite a high disease specificity, their usefulness for predicting the course of disease, the timing of liver transplantation, or disease recurrence after transplantation is limited. The realization that about 5% of patients with PBC do not display AMA has led to the identification of PBC-specific antinuclear autoantibodies directed against the nuclear pore complex and other targets. The overlap of PBC with autoimmune hepatitis and primary sclerosing cholangitis represents a diagnostic challenge in which autoantibody determinations play a central role and contribute to the administration of suitable treatment options.
Subject(s)
Autoimmune Diseases/diagnosis , Liver Cirrhosis, Biliary/diagnosis , Antibodies, Antinuclear/immunology , Autoantibodies/immunology , Autoantigens/immunology , Autoimmune Diseases/immunology , Female , Humans , Ketoglutarate Dehydrogenase Complex/immunology , Liver Cirrhosis, Biliary/immunology , Male , Pyruvate Dehydrogenase Complex/immunology , Serologic TestsABSTRACT
Primary biliary cirrhosis (PBC) has been classified as an autoimmune disease. It is characterized by a multitude of immune-mediated symptoms and phenomena. Humoral autoimmunity directed against mitochondrial auto-antigens or structures cross-reactive with these proteins represents the basis of one of the most specific tests in any autoimmune disease: the detection of auto-antibodies against pyruvate dehydrogenase. The molecular cloning and expression of antigens of the ketoacid dehydrogenase complex has led to the establishment of highly specific and reliable testing systems for anti-mitochondrial antibodies (AMA). The characterization of specific antinuclear auto-antibodies has contributed to the diagnosis of AMA-negative PBC and is an important marker in overlap syndromes of PBC and other autoimmune liver diseases.
Subject(s)
Antibodies, Anti-Idiotypic , Autoimmune Diseases/immunology , Liver Cirrhosis, Biliary/immunology , Mitochondria, Liver/immunology , Antibodies, Antinuclear/immunology , Antibody Formation , Autoimmunity , Humans , Ketoglutarate Dehydrogenase Complex/immunologyABSTRACT
Analysis of the primary structure of the lipoyl domain of the dihydrolipoamide acetyltransferase (PDC-E2) component of the porcine pyruvate dehydrogenase complex (PDC) reveals a high degree of homology with M2 antigen and human PDC-E2. The porcine PDC-E2 and the dihydrolipoamide succinyltransferase (OGDC-E2) component of the porcine 2-oxoglutarate dehydrogenase complex (OGDC) were identified as mitochondrial autoantigen with sera from patients with primary biliary cirrhosis (PBC). Immunodominant regions (autoepitopes) on the porcine-PDC-E2 component have been mapped to two regions around Lys-46 (outer lipoyl domain) and Lys-173 (inner lipoyl domain), which contained covalently bound lipoic acid prosthetic group. When these lipoyl domains were cleaved at Asp-45 or Asp-172 with endoproteinase Asp-N, the autoantigenicities of the two domains completely disappeared; this suggested the requirement of Asp-45 or Asp-172 residues for the immunoreaction with PBC sera. In addition, a single 14-amino acid epitope peptide histidine-substituted at Asp-172 did not exhibit competitive inhibition of autoantigen binding. Fragmentation of lipoyl domain of the porcine PDC-E2 by limited proteolysis and BrCN-cleavage after alkylation resulted in rapid loss of autoantigenicity. Enzymatic delipoylation and relipoylation of the complexed and free PDC-E2 and OGDC-E2 components did not influence immunoreactivity with PBC sera.
Subject(s)
Autoantibodies/immunology , Autoantigens/immunology , Immunodominant Epitopes/immunology , Ketoglutarate Dehydrogenase Complex/immunology , Liver Cirrhosis, Biliary/immunology , Pyruvate Dehydrogenase Complex/immunology , Amino Acid Sequence , Animals , Antibody Specificity , Autoantibodies/blood , Dihydrolipoyllysine-Residue Acetyltransferase , Humans , Liver Cirrhosis, Biliary/blood , Molecular Sequence Data , SwineABSTRACT
In this report, we demonstrate stimulation of T cell receptor (TCR) transgenic CD8 T cells by isolated major histocompatibility complex (MHC) class I H-2Ld complexes and antigenic peptide. This is the first demonstration of CD8 T cells activated by MHC and antigenic peptide in the absence of antigen priming. Furthermore, isolated MHC and a potent peptide antigen can stimulate phenotypically naive CD44- T cells to become CTL effectors and to produce interleukin-2 in nanogram per milliliter amounts. These results demonstrate that particular TCR antigen pairs may overcome the need for specialized antigen-presenting cells and have implications for mechanisms of autoimmunity and tolerance induction.
Subject(s)
CD8-Positive T-Lymphocytes/immunology , H-2 Antigens/immunology , Ketoglutarate Dehydrogenase Complex/immunology , Lymphocyte Activation , Oligopeptides/immunology , Animals , Antigen-Presenting Cells/immunology , CD8-Positive T-Lymphocytes/classification , CD8-Positive T-Lymphocytes/metabolism , Dose-Response Relationship, Immunologic , Female , H-2 Antigens/isolation & purification , H-2 Antigens/physiology , Histocompatibility Antigen H-2D , Hyaluronan Receptors , Immunophenotyping , Interleukin-2/biosynthesis , Isoantigens/immunology , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Oligopeptides/isolation & purification , Oligopeptides/pharmacology , T-Lymphocytes, Cytotoxic/immunology , TitrimetryABSTRACT
Pyruvate dehydrogenase complex (PDC), 2-oxo-glutarate dehydrogenase complex (OGDC), and the branched-chain 2-oxoacid dehydrogenase complex (BCOADC) constitute the 2-oxoacid dehydrogenase family of multienzyme complexes. These complexes, which are larger than ribosomes and which consist of multiple copies of E1, E2, and E3 subunits together with regulatory kinases and phosphatases and, in the case of PDC, an E3-binding protein (protein X), each play an important role in oxidative metabolism in mitochondria. Primary biliary cirrhosis (PBC) is associated with a high incidence of autoantibodies directed at mitochondrial autoantigens (the antimito-chondrial antibodies), identified as the E2 components of PDC, OGDC, and BCOADC, together with protein X and the E1 alpha and E1 beta subunits of PDC. The dominant B-cell autoepitope in PBC has been identified as the inner lipoic acid binding domain of PDC-E2, with the lipoic acid co-factor, which plays a critical role in E2 enzymatic activity, playing a role in autoantibody binding to antigen. Autoreactive CD4+ T cells specific for human PDC-E2 are also present in both the peripheral blood and liver mononuclear cell infiltrates of PBC patients. The mechanism of break-down of B-cell and T-cell self-tolerance to these ubiquitous mitochondrial antigens in such an organ-specific manner remains unclear. The apparent importance of autoreactive responses to these self-antigens does, however, raise the possibility that antigen-specific immunotherapy may offer a novel route to therapy in PBC.
Subject(s)
Autoimmune Diseases/enzymology , Ketone Oxidoreductases/immunology , Liver Cirrhosis, Biliary/enzymology , Multienzyme Complexes/immunology , 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) , Antigen-Antibody Reactions , Autoantibodies/immunology , Autoantigens/immunology , Autoimmune Diseases/immunology , Autoimmune Diseases/therapy , B-Lymphocytes/enzymology , B-Lymphocytes/immunology , Biochemical Phenomena , Biochemistry , Blood , CD4-Positive T-Lymphocytes/immunology , Epitopes , Humans , Immunotherapy , Ketoglutarate Dehydrogenase Complex/immunology , Liver/immunology , Liver/pathology , Liver Cirrhosis, Biliary/immunology , Liver Cirrhosis, Biliary/therapy , Mitochondria, Liver/enzymology , Mitochondria, Liver/immunology , Oxidation-Reduction , Peptides , Pyruvate Dehydrogenase Complex/immunology , Self Tolerance/immunology , Thioctic Acid/metabolismABSTRACT
The present study examined self-tolerance for T cell receptor (TCR) alpha beta intestinal intraepithelial lymphocytes (iIELs) using the 2C transgenic (Tg) mouse model specific for a peptide antigen (Ag) presented by the class I major histocompatibility complex H-2Ld. Although Tg+ T cells were largely deleted from the periphery of Ag+ mice, equivalent numbers of Tg iIELs were present in Ag+ compared to Ag- mice. Tg iIELs in Ag- mice contained CD8 alpha beta, CD8 alpha alpha, and CD4-CD8- subsets, whereas only CD8 alpha alpha and CD4-CD8- Tg iIEL subsets were detected in Ag+ mice. Analysis of surface markers revealed that Tg iIELs in Ag+ mice expressed decreased levels of Thy-1 and increased CD45R/B220 as compared to Ag- Tg iIELs. In response to activation with exogenous peptide or immobilized anti-TCR mAB, iIELs from Ag- mice proliferated at high levels and produced interleukin (IL)-2 and interferon (IFN)-gamma, while Tg+ iIELs from Ag+ mice proliferated at low levels and failed to produce detectable IL-2 or IFN-gamma. Activation of sorted iIEL subsets from Ag- mice revealed that CD8 alpha alpha and CD4-CD8- subsets produced low levels of IL-2 and IFN-gamma in response to activation with antigen-presenting cells and added peptide or immobilized anti-TCR mAb, while CD8 alpha beta + iIELs responded to endogenous levels of peptide. In response to APC and exogenous peptide, sorted iIEL subsets from Ag+ mice produced IL-2 and IFN-gamma, and proliferated at greatly reduced levels compared to corresponding subsets from Ag- mice. Analysis of cytokine mRNA levels revealed that activation in vitro induced IL-2 mRNA only in Ag-, but not Ag+ iIELs, whereas a high level of IL-4 mRNA induction was detected in Tg+ iIELs from Ag+ mice, and to a lesser degree, from Ag- mice. These data suggest that tolerance for Tg+ iIELs resulted in the deletion of CD8 alpha beta + subsets and the persistence of Tg+ iIEL subsets with decreased sensitivity to endogenous levels of self-peptide. A comparison of the cytokine profiles expressed by Tg+ iIEL subsets in Ag- and Ag+ mice suggested that tolerance induction had involved the functional deviation of cells from TC1 (T helper-1-like) to a less inflammatory TC2 (T helper-2-like) phenotype capable of mediating humoral immune responses in the mucosa.
Subject(s)
Immunity, Mucosal/immunology , T-Lymphocyte Subsets/immunology , Animals , Cytokines/biosynthesis , Dose-Response Relationship, Immunologic , Female , H-2 Antigens/immunology , Immune Tolerance , Immunophenotyping , Interleukin-2/biosynthesis , Interleukin-4/biosynthesis , Intestinal Mucosa/cytology , Intestinal Mucosa/immunology , Ketoglutarate Dehydrogenase Complex/genetics , Ketoglutarate Dehydrogenase Complex/immunology , Lymph Nodes/cytology , Lymphocyte Activation , Male , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Transgenic , Receptors, Antigen, T-Cell, alpha-betaABSTRACT
The detection of antimitochondrial autoantibodies (AMAs) is critical in the diagnosis of primary biliary cirrhosis (PBC). However, conventional laboratory assays to detect AMA are dependent on the time-consuming method of immunofluorescence microscopy, a method often plagued by problems of nonspecificity. AMAs react against mitochondrial autoantigens including the E2 components of the pyruvate dehydrogenase complex (PDC-E2), the branched-chain 2-oxo-acid dehydrogenase complex (BCOADC-E2), and the 2-oxo-glutarate dehydrogenase complex (OGDC-E2). Interestingly, the immunodominant epitopes of PDC-E2, BCOADC-E2, and OGDC-E2 are all conformational lipoate binding sites, but antibodies against them do not cross-react. Although 80% to 90% of sera from patients with PBC react to PDC-E2, approximately 10% patients with PBC react only to BCOADC-E2 and/or OGDC-E2. We have taken advantage of our epitope-mapping studies of the E2 components of PDC, BCOADC, and OGDC, and constructed a "designer" hybrid clone, designated as pML-MIT3, that coexpresses the immunodominant epitopes within the three distinct lipoyl domains. We examined a total of 321 sera, including 186 sera from patients with PBC, to test the immunoreactivity of pMIT3. Of 186 sera from patients with PBC, 152 sera (81.7%) reacted with recombinant fusion protein of PDC-E2, whereas 171 sera (91.9%) showed positive reactivities when probed by immunoblotting against the recombinant fusion protein expressed from the pML-MIT3 clone. Of 34 PBC sera that did not react with recombinant PDC-E2, 18 sera contained BCOADC-E2-specific AMA and 1 serum possessed only OGDC-E2-specific AMA. We also developed an enzyme-linked immunosorbent assay (ELISA), using affinity-purified recombinant fusion protein of pML-MIT3 clone as the antigen source, to quantify specific AMAs in patients with PBC. None of the 135 control sera from patients with primary sclerosing cholangitis (PSC), chronic autoimmune hepatitis (CAH), systemic lupus erythematosus (SLE), or healthy volunteers showed significant reactivity against pML-MIT3 recombinant fusion protein in the ELISA assay. Our results indicate that an ELISA using recombinant, cloned autoantigen of pML-MIT3 is a powerful and very specific method for the detection of AMA.
Subject(s)
Autoantibodies/blood , Autoantigens/immunology , Cloning, Molecular/methods , Epitopes/analysis , Ketoglutarate Dehydrogenase Complex/immunology , Ketone Oxidoreductases/immunology , Liver Cirrhosis, Biliary/diagnosis , Mitochondria/immunology , Multienzyme Complexes/immunology , Polymerase Chain Reaction/methods , Pyruvate Dehydrogenase Complex/immunology , 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) , Animals , Base Sequence , Binding Sites , Cattle , DNA Primers , Diagnosis, Differential , Enzyme-Linked Immunosorbent Assay/methods , Fluorescent Antibody Technique , Humans , Liver Cirrhosis, Biliary/blood , Liver Cirrhosis, Biliary/immunology , Molecular Sequence Data , Protein Multimerization , Rats , Recombinant Fusion Proteins/immunology , Reference Values , Reproducibility of Results , Restriction Mapping , Sensitivity and Specificity , Thioctic Acid/metabolismABSTRACT
To determine whether the reduction in brain alpha-ketoglutarate dehydrogenase complex activity in Alzheimer's disease (AD) is associated with an abnormality in one of its three constituent enzyme subunits, we measured protein levels of alpha-ketoglutarate dehydrogenase (El), dihydrolipoamide succinyltransferase (E2), and dihydrolipoamide dehydrogenase (E3), in postmortem brain of 29 patients with AD (mean age, 73 years; age range of onset, 50-78 years) and 29 control subjects. In the AD group protein levels of all three subunits were significantly reduced by 23 to 41% in the temporal cortex, whereas in the parietal cortex (El: -28%; E3: -32%) and hippocampus (E3: -33%) significant changes were limited to El and E3. alpha-Ketoglutarate dehydrogenase complex activities were more markedly reduced (by 46-68%) and did not correlate with protein levels, suggesting that decreased enzyme activity cannot be primarily explained by loss of alpha-ketoglutarate dehydrogenase complex protein. We did not find two E2 immunoreactive forms in the brain of any patient, as has been reported in fibroblasts of patients with very-early-onset chromosome 14-linked AD. We conclude that brain protein and activity levels of alpha-ketoglutarate dehydrogenase complex are reduced in patients with AD who have onset after 50 years and suggest that these changes, which are also observed in other human brain disorders, may represent a nonspecific consequence of different neurodegenerative processes. Nevertheless, reduced levels of this rate-limiting enzyme of the Krebs cycle could contribute to the brain neurodegenerative mechanisms of AD.
Subject(s)
Alzheimer Disease/enzymology , Brain/enzymology , Ketoglutarate Dehydrogenase Complex/metabolism , Nerve Tissue Proteins/metabolism , Age Factors , Aged , Autopsy , Blotting, Western , Brain/pathology , Choline O-Acetyltransferase/metabolism , Chromosomes, Human, Pair 14 , Citrate (si)-Synthase/metabolism , Fibroblasts/enzymology , Humans , Ketoglutarate Dehydrogenase Complex/analysis , Ketoglutarate Dehydrogenase Complex/immunology , Middle Aged , Time FactorsABSTRACT
Five different target mitochondrial autoantigens recognized by sera from patients with primary biliary cirrhosis (PBC) have been identified as subunits of the following 2-oxo acid dehydrogenase complexes: the pyruvate dehydrogenase complex (PDC), the branched chain 2-oxo acid dehydrogenase complex (BCOADC), and the 2-oxoglutarate dehydrogenase complex (OGDC). Unlike the E2 subunits of PDC (PDC-E2) and BCOADC (BCOADC-E2), the E2 subunits of OGDC (OGDC-E2) reactivity of PBC sera and the reactive epitope of OGDC-D2 have not hitherto been studied in detail. In this report, we took advantage of a recombinant fusion protein for OGDC-E2 to address these issues. Eighty of 268 (29.9%) PBC patient sera but none of the 45 controls reacted with recombinant OGDC-E2. The recombinant OGDC-E2 was judged to express the immunodominant epitope, because when sera from patients with PBC were preabsorbed with the recombinant fusion protein, such sera were depleted of reactivity against 48 kD OGDC-E2 when probed on beef heart mitochondria (BHM) but retained reactivity toward PDC-E2 and/or BCOADC-E2. Furthermore, affinity-purified PBC sera against recombinant OGDC-E2 reacted only with native OGDC-E2 and not with any other enzyme components of the 2-oxo acid dehydrogenase complex. Antimitochondrial autoantibodies (AMA) against OGDC-E2 included immunoglobulin (Ig)G2, IgG3 and IgM and the relative titers were as follows: IgG2 > IgG3 > IgM. Finally, using overlapping recombinant polypeptides, it was determined that a minimum of 81 amino acids (residues 67-147) corresponding to the lipoyl domain of OGDC-E2 are necessary for reactivity, suggesting that a conformational autoepitope is recognized by AMA. These data suggest that each of the 2-oxo acid dehydrogenase enzymes has distinct antigenicity despite their similarities in structure and function. The availability of recombinant OGDC-E2 autoantigen will allow the design of additional studies to further our understanding of the role of mitochondrial autoantigens in the pathogenesis of PBC.
Subject(s)
Autoantibodies/immunology , Autoantigens/immunology , Epitopes/immunology , Ketoglutarate Dehydrogenase Complex/immunology , Liver Cirrhosis, Biliary/immunology , Animals , Antigen-Antibody Reactions , Autoantibodies/blood , Base Sequence , Humans , Immunoblotting , Ketoglutarate Dehydrogenase Complex/genetics , Liver Cirrhosis, Biliary/enzymology , Mitochondria/immunology , Molecular Sequence Data , Rats , Recombinant Fusion Proteins/immunologyABSTRACT
It has been shown that monoclonal antibody (mAb) F7F10 raised against pyruvate dehydrogenase component (E1) of pigeon breast muscle pyruvate dehydrogenase complex (PDC) has no influence on the E1 activity, measured in the system with artificial oxidants. However it inhibited the full NAD+ and coenzyme A dependent activity of PDC. The competition of the F7F10 antibody with the E2 component of PDC for the binding with E1 was revealed by immunoenzymatic and kinetic analysis. It is suggested that F7F10 mAb interacts with an antigenic determinant, located in the immediate vicinity of or overlapping with the E1 region, responsible for the interaction with the E2 component of PDC.
Subject(s)
Antibodies, Monoclonal/pharmacology , Epitopes/immunology , Pyruvate Dehydrogenase Complex/immunology , Animals , Antibodies, Monoclonal/metabolism , Binding Sites, Antibody , Binding, Competitive , Columbidae , Epitopes/metabolism , Humans , Ketoglutarate Dehydrogenase Complex/drug effects , Ketoglutarate Dehydrogenase Complex/immunology , Kinetics , Muscles/enzymology , Myocardium/enzymology , NAD/metabolism , Pyruvate Dehydrogenase Complex/drug effects , Pyruvate Dehydrogenase Complex/metabolism , Thiamine Pyrophosphate/immunology , Thiamine Pyrophosphate/metabolismABSTRACT
Anti-CF3CO antibodies, monospecific toward trifluoroacetylated proteins (CF3CO-proteins), which are elicited in experimental animals and humans exposed to the anesthetic agent halothane, cross-react with an unknown protein of approximately 52 kDa, constitutively expressed in tissues of experimental animals and humans not previously exposed to the agent. Using anti-CF3CO antibody, the protein(s) of 52 kDa could be immunoprecipitated from solubilized rat heart homogenate. Two-dimensional gel electrophoretic analysis revealed the presence of distinct major (P1, P2) and minor (P3, P4, P5) protein components with apparent molecular masses of 52 kDa. From each of the components P1 and P2, the amino acid sequences of three peptides were determined and found to exhibit 100% identity with the corresponding amino acid sequences of the E2 subunit of the rat 2-oxoglutarate dehydrogenase complex (OGDC). Additionally to the E2 subunit of OGDC, anti-CF3CO antibody also recognized on immunoblots the purified E2 subunit of the branched chain 2-oxoacid dehydrogenase complex (BCOADC) and protein X, a constituent of the pyruvate dehydrogenase complex (PDC), in a manner sensitive to competition by N6-(trifluoroacetyl)-L-lysine (CF3CO-Lys), 6(RS)-lipoic acid, and N6-(6(RS)-lipoyl)-L-lysine (lipoyl-Lys). Furthermore, a discrete population of autoantibodies was identified in sera of patients with halothane hepatitis which could not discriminate between the lipoylated target epitope present on the E2 subunit of OGDC and epitopes on CF3CO-RSA, used as model for CF3CO-proteins. These data suggest that the autoantigenicity of these proteins in halothane hepatitis is based on the molecular mimicry of CF3CO-Lys by lipoic acid, the prosthetic group common to protein X and the E2 subunits of OGDC and BCOADC.